| Secondary |
| Product Used For Unknown Indication |
18.1% |
| Pemphigus |
16.7% |
| Osteoporosis |
13.9% |
| Osteoporosis Prophylaxis |
13.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
5.6% |
| Systemic Lupus Erythematosus |
5.6% |
| Hypertension |
4.2% |
| Arrhythmia |
2.8% |
| Colon Cancer |
2.8% |
| Rheumatoid Arthritis |
2.8% |
| Asthma |
1.4% |
| Bile Acid Malabsorption |
1.4% |
| Blood Cholesterol |
1.4% |
| Depression |
1.4% |
| Dizziness |
1.4% |
| Drug Use For Unknown Indication |
1.4% |
| Epilepsy |
1.4% |
| Gastrointestinal Pain |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Hyperthyroidism |
1.4% |
|
| Trismus |
28.6% |
| Renal Impairment |
14.3% |
| Renal Failure Acute |
9.5% |
| Urinary Tract Infection |
9.5% |
| Angioedema |
4.8% |
| Drug Interaction |
4.8% |
| Emotional Distress |
4.8% |
| Eye Swelling |
4.8% |
| Joint Stiffness |
4.8% |
| Osteoporosis |
4.8% |
| Renal Failure |
4.8% |
| Supraventricular Tachycardia |
4.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
41.8% |
| Drug Use For Unknown Indication |
12.6% |
| Rheumatoid Arthritis |
6.8% |
| Osteoporosis |
6.5% |
| Pain |
4.9% |
| Hypertension |
3.8% |
| Crohn's Disease |
3.5% |
| Prophylaxis |
2.7% |
| Depression |
2.6% |
| Pneumonia |
2.3% |
| Breast Cancer |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Pulmonary Embolism |
1.5% |
| Lower Respiratory Tract Infection |
1.2% |
| Asthma |
1.1% |
| Atrial Fibrillation |
1.1% |
| Prostate Cancer |
1.1% |
| Anxiety |
1.0% |
| Gastritis |
1.0% |
| Schizophrenia |
1.0% |
|
| Vomiting |
11.3% |
| Renal Failure Acute |
9.3% |
| Urinary Tract Infection |
6.5% |
| Death |
6.1% |
| Dyspnoea |
5.3% |
| Hyponatraemia |
5.3% |
| Pneumonia |
5.3% |
| Sepsis |
4.9% |
| Rectal Haemorrhage |
4.5% |
| Toxic Epidermal Necrolysis |
4.5% |
| White Blood Cell Count Increased |
4.5% |
| Gastrointestinal Haemorrhage |
4.0% |
| Syncope |
4.0% |
| Hyperkalaemia |
3.6% |
| Pulmonary Fibrosis |
3.6% |
| Swollen Tongue |
3.6% |
| Urosepsis |
3.6% |
| Vision Blurred |
3.6% |
| Drug Interaction |
3.2% |
| Haemoglobin Decreased |
3.2% |
|
| Interacting |
| Gastrointestinal Pain |
100.0% |
|
|
